Global Nuclear Medicine & Radio Pharmaceuticals Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Based on the Nuclear Medicine & Radio Pharmaceuticals market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Nuclear Medicine & Radio Pharmaceuticals market covered in Chapter 5:
Siemens Healthcare
Shimadzu
Toshiba
Biosensors International Group, Ltd.
Hitachi
Carestream
GE Healthcare
TriFoil Imaging
Philips Healthcare
Esaote
In Chapter 6, on the basis of types, the Nuclear Medicine & Radio Pharmaceuticals market from 2015 to 2025 is primarily split into:
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
In Chapter 7, on the basis of applications, the Nuclear Medicine & Radio Pharmaceuticals market from 2015 to 2025 covers:
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Nuclear Medicine & Radio Pharmaceuticals market covered in Chapter 5:
Siemens Healthcare
Shimadzu
Toshiba
Biosensors International Group, Ltd.
Hitachi
Carestream
GE Healthcare
TriFoil Imaging
Philips Healthcare
Esaote
In Chapter 6, on the basis of types, the Nuclear Medicine & Radio Pharmaceuticals market from 2015 to 2025 is primarily split into:
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
In Chapter 7, on the basis of applications, the Nuclear Medicine & Radio Pharmaceuticals market from 2015 to 2025 covers:
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Siemens Healthcare
5.1.1 Siemens Healthcare Company Profile
5.1.2 Siemens Healthcare Business Overview
5.1.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.2 Shimadzu
5.2.1 Shimadzu Company Profile
5.2.2 Shimadzu Business Overview
5.2.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.3 Toshiba
5.3.1 Toshiba Company Profile
5.3.2 Toshiba Business Overview
5.3.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Toshiba Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.4 Biosensors International Group, Ltd.
5.4.1 Biosensors International Group, Ltd. Company Profile
5.4.2 Biosensors International Group, Ltd. Business Overview
5.4.3 Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.5 Hitachi
5.5.1 Hitachi Company Profile
5.5.2 Hitachi Business Overview
5.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Hitachi Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.6 Carestream
5.6.1 Carestream Company Profile
5.6.2 Carestream Business Overview
5.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Carestream Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.7 GE Healthcare
5.7.1 GE Healthcare Company Profile
5.7.2 GE Healthcare Business Overview
5.7.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.8 TriFoil Imaging
5.8.1 TriFoil Imaging Company Profile
5.8.2 TriFoil Imaging Business Overview
5.8.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.9 Philips Healthcare
5.9.1 Philips Healthcare Company Profile
5.9.2 Philips Healthcare Business Overview
5.9.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.10 Esaote
5.10.1 Esaote Company Profile
5.10.2 Esaote Business Overview
5.10.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Esaote Nuclear Medicine & Radio Pharmaceuticals Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Types (2015-2020)
6.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Types (2015-2020)
6.1.3 Global Nuclear Medicine & Radio Pharmaceuticals Price by Types (2015-2020)
6.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Types (2020-2025)
6.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Price and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
6.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Price and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
6.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Market Revenue and Sales Forecast (2020-2025)
6.4.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Applications (2015-2020)
7.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Applications (2015-2020)
7.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Applications (2020-2025)
7.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue, Sales and Growth Rate of Diagnostic Applications: SPECT, PET. (2015-2020)
7.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue, Sales and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2015-2020)
7.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Diagnostic Applications: SPECT, PET. Market Revenue and Sales Forecast (2020-2025)
7.4.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2015-2020)
8.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue by Regions (2015-2020)
8.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Regions (2020-2025)
9 NORTH AMERICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
9.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
9.4 North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
9.6.1 U.S. Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
9.6.2 Canada Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
9.6.3 Mexico Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10 EUROPE NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
10.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
10.4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
10.6.1 Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.2 United Kingdom Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.3 France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.4 Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.5 Spain Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.6 Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11 ASIA-PACIFIC NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
11.6.1 China Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.2 Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.3 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.4 Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.5 India Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
12 SOUTH AMERICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
12.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
12.4 South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
12.6.1 Brazil Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
12.6.2 Argentina Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
12.6.3 Columbia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
13 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
13.6.1 UAE Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
13.6.2 Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
13.6.3 South Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Siemens Healthcare
5.1.1 Siemens Healthcare Company Profile
5.1.2 Siemens Healthcare Business Overview
5.1.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.2 Shimadzu
5.2.1 Shimadzu Company Profile
5.2.2 Shimadzu Business Overview
5.2.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.3 Toshiba
5.3.1 Toshiba Company Profile
5.3.2 Toshiba Business Overview
5.3.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Toshiba Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.4 Biosensors International Group, Ltd.
5.4.1 Biosensors International Group, Ltd. Company Profile
5.4.2 Biosensors International Group, Ltd. Business Overview
5.4.3 Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.5 Hitachi
5.5.1 Hitachi Company Profile
5.5.2 Hitachi Business Overview
5.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Hitachi Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.6 Carestream
5.6.1 Carestream Company Profile
5.6.2 Carestream Business Overview
5.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Carestream Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.7 GE Healthcare
5.7.1 GE Healthcare Company Profile
5.7.2 GE Healthcare Business Overview
5.7.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.8 TriFoil Imaging
5.8.1 TriFoil Imaging Company Profile
5.8.2 TriFoil Imaging Business Overview
5.8.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.9 Philips Healthcare
5.9.1 Philips Healthcare Company Profile
5.9.2 Philips Healthcare Business Overview
5.9.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Introduction
5.10 Esaote
5.10.1 Esaote Company Profile
5.10.2 Esaote Business Overview
5.10.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Esaote Nuclear Medicine & Radio Pharmaceuticals Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Types (2015-2020)
6.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Types (2015-2020)
6.1.3 Global Nuclear Medicine & Radio Pharmaceuticals Price by Types (2015-2020)
6.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Types (2020-2025)
6.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Price and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
6.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Price and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
6.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Market Revenue and Sales Forecast (2020-2025)
6.4.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Applications (2015-2020)
7.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Applications (2015-2020)
7.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Applications (2020-2025)
7.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue, Sales and Growth Rate of Diagnostic Applications: SPECT, PET. (2015-2020)
7.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue, Sales and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2015-2020)
7.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Diagnostic Applications: SPECT, PET. Market Revenue and Sales Forecast (2020-2025)
7.4.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2015-2020)
8.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue by Regions (2015-2020)
8.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Regions (2020-2025)
9 NORTH AMERICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
9.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
9.4 North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
9.6.1 U.S. Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
9.6.2 Canada Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
9.6.3 Mexico Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10 EUROPE NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
10.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
10.4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
10.6.1 Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.2 United Kingdom Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.3 France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.4 Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.5 Spain Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
10.6.6 Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11 ASIA-PACIFIC NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
11.6.1 China Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.2 Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.3 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.4 Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
11.6.5 India Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
12 SOUTH AMERICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
12.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
12.4 South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
12.6.1 Brazil Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
12.6.2 Argentina Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
12.6.3 Columbia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
13 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Analysis by Country
13.6.1 UAE Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
13.6.2 Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
13.6.3 South Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate 2015-2025
Table Nuclear Medicine & Radio Pharmaceuticals Key Market Segments
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) Segment by Type from 2015-2020
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Nuclear Medicine & Radio Pharmaceuticals
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Siemens Healthcare Company Profile
Table Siemens Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Siemens Healthcare Production and Growth Rate
Figure Siemens Healthcare Market Revenue ($) Market Share 2015-2020
Table Shimadzu Company Profile
Table Shimadzu Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shimadzu Production and Growth Rate
Figure Shimadzu Market Revenue ($) Market Share 2015-2020
Table Toshiba Company Profile
Table Toshiba Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Toshiba Production and Growth Rate
Figure Toshiba Market Revenue ($) Market Share 2015-2020
Table Biosensors International Group, Ltd. Company Profile
Table Biosensors International Group, Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biosensors International Group, Ltd. Production and Growth Rate
Figure Biosensors International Group, Ltd. Market Revenue ($) Market Share 2015-2020
Table Hitachi Company Profile
Table Hitachi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hitachi Production and Growth Rate
Figure Hitachi Market Revenue ($) Market Share 2015-2020
Table Carestream Company Profile
Table Carestream Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Carestream Production and Growth Rate
Figure Carestream Market Revenue ($) Market Share 2015-2020
Table GE Healthcare Company Profile
Table GE Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GE Healthcare Production and Growth Rate
Figure GE Healthcare Market Revenue ($) Market Share 2015-2020
Table TriFoil Imaging Company Profile
Table TriFoil Imaging Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure TriFoil Imaging Production and Growth Rate
Figure TriFoil Imaging Market Revenue ($) Market Share 2015-2020
Table Philips Healthcare Company Profile
Table Philips Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Philips Healthcare Production and Growth Rate
Figure Philips Healthcare Market Revenue ($) Market Share 2015-2020
Table Esaote Company Profile
Table Esaote Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Esaote Production and Growth Rate
Figure Esaote Market Revenue ($) Market Share 2015-2020
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue ($) by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Price ($) by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales by Types (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales Share by Types (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) by Types (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue Share by Types (2020-2025)
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Sales and Growth Rate (2015-2020)
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Price (2015-2020)
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Price (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue ($) by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales by Applications (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales Share by Applications (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Diagnostic Applications: SPECT, PET. Sales and Growth Rate (2015-2020)
Figure Global Diagnostic Applications: SPECT, PET. Price (2015-2020)
Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Price (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Diagnostic Applications: SPECT, PET. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Diagnostic Applications: SPECT, PET. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions in 2019
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2019
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales by Regions (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales Share by Regions (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Italy Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Spain Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Russia Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure India Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure UAE Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate 2015-2025
Table Nuclear Medicine & Radio Pharmaceuticals Key Market Segments
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) Segment by Type from 2015-2020
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Nuclear Medicine & Radio Pharmaceuticals
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Siemens Healthcare Company Profile
Table Siemens Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Siemens Healthcare Production and Growth Rate
Figure Siemens Healthcare Market Revenue ($) Market Share 2015-2020
Table Shimadzu Company Profile
Table Shimadzu Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shimadzu Production and Growth Rate
Figure Shimadzu Market Revenue ($) Market Share 2015-2020
Table Toshiba Company Profile
Table Toshiba Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Toshiba Production and Growth Rate
Figure Toshiba Market Revenue ($) Market Share 2015-2020
Table Biosensors International Group, Ltd. Company Profile
Table Biosensors International Group, Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biosensors International Group, Ltd. Production and Growth Rate
Figure Biosensors International Group, Ltd. Market Revenue ($) Market Share 2015-2020
Table Hitachi Company Profile
Table Hitachi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hitachi Production and Growth Rate
Figure Hitachi Market Revenue ($) Market Share 2015-2020
Table Carestream Company Profile
Table Carestream Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Carestream Production and Growth Rate
Figure Carestream Market Revenue ($) Market Share 2015-2020
Table GE Healthcare Company Profile
Table GE Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GE Healthcare Production and Growth Rate
Figure GE Healthcare Market Revenue ($) Market Share 2015-2020
Table TriFoil Imaging Company Profile
Table TriFoil Imaging Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure TriFoil Imaging Production and Growth Rate
Figure TriFoil Imaging Market Revenue ($) Market Share 2015-2020
Table Philips Healthcare Company Profile
Table Philips Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Philips Healthcare Production and Growth Rate
Figure Philips Healthcare Market Revenue ($) Market Share 2015-2020
Table Esaote Company Profile
Table Esaote Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Esaote Production and Growth Rate
Figure Esaote Market Revenue ($) Market Share 2015-2020
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue ($) by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Price ($) by Types (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales by Types (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales Share by Types (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) by Types (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue Share by Types (2020-2025)
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Sales and Growth Rate (2015-2020)
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Price (2015-2020)
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Price (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue ($) by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Applications (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales by Applications (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales Share by Applications (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Diagnostic Applications: SPECT, PET. Sales and Growth Rate (2015-2020)
Figure Global Diagnostic Applications: SPECT, PET. Price (2015-2020)
Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Price (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Diagnostic Applications: SPECT, PET. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Diagnostic Applications: SPECT, PET. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Revenue ($) and Growth Rate Forecast of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions in 2019
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2019
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales by Regions (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales Share by Regions (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Italy Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Spain Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Russia Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure India Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast Sales (2020-2025)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure UAE Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Market Sales and Growth Rate (2015-2020)
